Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Bellerophon Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2023
- Shares held
- 1.27M
- +75.4K (+6.3%) vs. Q2 2023
- Total value
- $506.6K
- −$318.4K (−38.6%) vs. Q2 2023
- New holders
- 4
- 3 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 33 | $13 | 0.00% | 00.0% | Unchanged |
| GPS Wealth Strategies Group, LLC | 38 | $15 | 0.00% | 00.0% | Unchanged |
| Global Wealth Strategies & Associates | 50 | $20 | 0.00% | +50 | New |
| Qube Research & Technologies Ltd | 52 | $21 | 0.00% | +52 | New |
| Advisor Group Holdings, Inc. | 557 | $221 | 0.00% | −30,057−98.2% | Reduced |
| US Bancorp | 1,221 | $485 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,100 | $840 | 0.00% | −1,800−46.2% | Reduced |
| PFS Partners, LLC | 6,000 | $2.39K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,135 | $2.84K | 0.00% | −15−0.2% | Reduced |
| Raymond James & Associates | 10,000 | $3.98K | 0.00% | −1,097−9.9% | Reduced |
| Susquehanna International Group, LLP | 15,313 | $6.13K | 0.00% | +15,313 | New |
| Two Sigma Advisers, LP | 21,500 | $8.55K | 0.00% | +6,600+44.3% | Added |
| Northern Trust Corp | 30,251 | $12.0K | 0.00% | −7,970−20.9% | Reduced |
| State Street Corp | 30,127 | $12.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 42,717 | $17.1K | 0.00% | +42,717 | New |
| Renaissance Technologies LLC | 59,499 | $24.0K | 0.00% | −17,800−23.0% | Reduced |
| Geode Capital Management, LLC | 95,656 | $38.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 113,911 | $45.3K | 0.00% | +10,124+9.8% | Added |
| BlackRock Inc. | 127,723 | $50.8K | 0.00% | −2,153−1.7% | Reduced |
| Vanguard Group Inc | 145,810 | $58.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 180,066 | $71.6K | 0.00% | −20,009−10.0% | Reduced |
| Acadian Asset Management LLC | 383,178 | $152.0K | 0.00% | +117,925+44.5% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,870−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,355−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |